
Elpiscience Biopharmaceuticals
Develops cutting-edge immunotherapies to fight cancer.
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
* | N/A | N/A | IPO |
Total Funding | 000k |

CDH Investments(exited)

Lilly Asia Ventures(exited)

Oriza Holdings(exited)

ShenZhen GTJA Investment Group(exited)

Cormorant Asset Management(exited)

Maison Capital(exited)

Superstring Capital(exited)

Hillhouse Capital(exited)

Dyee Capital(exited)

Pluto Connection Limited(exited)

Unifortune Fund(exited)

Hyfinity Investments(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.